Diminished complement-activating capacity through the classical pathway in sera from type 2 diabetes mellitus

References

• Choy LN, Rosen BS, Spiegelman BM. (1992). Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem, 267, 12736–41
   PubMed Web of Science ®Google Scholar
• Cianflone K, Xia Z, Chen LY. (2003). Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta, 1609, 127–43
   PubMed Web of Science ®Google Scholar
• Duchateau J, Schreyen H, Dorchy H. (1992). Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro. Diabete Metab, 18, 272–6
   Google Scholar
• Ebeling P, Teppo AM, Koistinen HA, Koivisto VA. (2001). Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes. Metabolism, 50, 283–7
   PubMedGoogle Scholar
• Figueredo A, Ibarra JL, Bagazgoitia J, et al. (1993). Plasma C3d levels and ischemic heart disease in type II diabetes. Diabetes Care, 16, 445–9
   Google Scholar
• Fujita T, Satomura A, Hidaka M, et al. (1999a). Inhibitory effect of free sialic acid on complement activation and its significance in hypocomplementemic glomerulonephritis. J Clin Lab Anal, 13, 173–9
   Google Scholar
• Fujita T, Ohi H, Endo M, et al. (1999b). The role of sialidase in the development of hypocomplementemia in postinfectious acute glomerulonephritis. Clin Immunol, 92, 97–102
   Google Scholar
• Fujita T, Fujioka T, Murakami T, et al. (2007). Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein. J Clin Lab Anal, 21, 14–23
   Google Scholar
• Fujita T, Shimizu C, Fuke Y, et al. (2011). Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy. Diab Res Clin. Prac, [Published on line 26 March 2011]
   Google Scholar
• Gabrielsson BG, Johansson JM, Lönn M, et al. (2003). High expression of complement components in omental adipose tissue in obese men. Obes Res, 11, 699–708
   PubMedGoogle Scholar
• Gaillard O, Meillet D, Bordas-Fonfrède M, et al. (1993). Application of the time-resolved immunofluorometric assay to the study of C3 complement component glycation in vitro and in vivo. Eur J Clin Chem Clin Biochem, 31, 749–52
   Google Scholar
• Geerlings SE, Hoepelman AI. (1999). Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol, 26, 259–65
   PubMed Web of Science ®Google Scholar
• Hammond KS, Papermaster DS. (1976). Fluorometric assay of sialic acid in the picomole range: A modification of ht ethiobarbituric acid assay. Anal Biochem, 74, 292–7
   PubMed Web of Science ®Google Scholar
• Hostetter MK. (1990). Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes, 39, 271–5
   PubMed Web of Science ®Google Scholar
• Karcher D, Lowenthal A, Thomar H, Noppe M (1981). Serological identification of viral antigens after electrophoretic transfer. J Immunol Methods, 43, 175–9
   Google Scholar
• Katz S, Klein B, Elian I, et al. (1983). Phagocytotic activity of monocytes from diabetic patients. Diabetes Care, 6, 479–82
   PubMed Web of Science ®Google Scholar
• Kolb WP, Morrow PR, Tamerius JD. (1989). Ba and Bb fragments of Factor B activation: Fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement Inflam, 6, 175–204
   PubMedGoogle Scholar
• Ohno Y, Aoki N, Nishimura A. (1993). In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 77, 1072–7
   PubMed Web of Science ®Google Scholar
• Pangburn MK, Müller-Eberhard HJ. (1978). Complement C3 convertase: Cell surfase restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc Natl Acad Sci U S A, 75, 2416–20
   PubMedGoogle Scholar
• Rosen A, Ek K, Aman P. (1979). Agarose isoelectric focusing of native human immunoglobulin M and a2-macroglobulin. J Immunol Methods, 28, 1–11
   Google Scholar
• Schauer R. (1982). Chemistry, metabolism, and biological functions of sialic acids. In: Tipson RS, Horton D et al. eds. Adv. Carbohydr. Chem. Biochem. Vol. 40, London: Academic Press, pp.131–234
   Google Scholar
• Schauer R. (1985). Sialic acids and their role as biological masks. In: Hall J. ed. Trends in Biological Sciences Vol. 10, Amsterdam: Elsevier Science Publishers, pp.357–60
   Google Scholar
• Schauer R, Shukla AK, Schröder C. (1984). The anti-recognition function of sialic acid: Studies with erythrocytes and macrophages. Pure Appl Chem, 56, 907–21
   Google Scholar
• Shimizu C, Fujita T, Fuke Y, et al. (2011). High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus. Mod Rheumatol, [Published on line 09 June 2011]
   Google Scholar
• Tamerius JD, Pangburn MK, Müller-Eberhard HJ. (1985). Detection of a neoantigen on human C3bi and C3d by monoclonal antibody. J immunol, 135, 2015–19
   Google Scholar
• Tilg H, Moschen AR. (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol, 6, 772–83
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci U S A, 76, 4350–4
   PubMed Web of Science ®Google Scholar
• Walport MJ. (2001a). Complement: First of two parts. N Engl J Med, 344, 1058–66
   PubMed Web of Science ®Google Scholar
• Walport MJ. (2001b). Complement: Second of two parts. N Engl J Med, 344, 1140–4
   PubMed Web of Science ®Google Scholar
• Wisse BE. (2004). The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol, 15, 2792–800
   PubMed Web of Science ®Google Scholar
• Yilmaz FM, Yilmaz G, Erdeve SS, et al. (2007). Serum sialic acid, hs-CRP and oxidative stress parameters in obese children. J Pediatr Endocrinol Metab, 20, 205–10
   PubMed Web of Science ®Google Scholar